Our aim at KMH is to improve healthcare through educational research studies.
We pride ourselves on providing the highest quality imaging for our over 50 clinical research studies through our partnership with GE healthcare. GE’s state of the art technology coupled with our experience and clinical expertise, positions us as industry leaders in research.
KMH has over 15 years of medical data on cardiac disease, variant cancers, ambulatory monitoring and more.
Currently, we are active in numerous clinical trials involving multi-modality imaging to determine the efficacy of various medications for the treatment of Alzheimer’s disease, cardiac disease, prostate cancer, crohns disease, digestive diseases, inflammation and various types of arthritis.
We have worked collaboratively with many top pharmaceutical companies on these studies including: Abbvie, Amgen, Anavex, AstraZeneca, Biogen, Eisai, Eli Lilly, Genentech, Janssen, Merck, Novartis, Pfizer, Roche, and Sanofi.
We look forward to continuing to grow these relationships and develop new research opportunities.
For research inquiries: